Patient-Specific Risk Factors and Clinical Correlates of Euglycemic Diabetic Ketoacidosis in Patients on Sodium-Glucose Co-Transporter-2 Inhibitors

Background: Sodium-Glucose Co-Transporter-2 Inhibitors (SGLT-2i) association with euglycemic diabetic ketoacidosis (EDKA) has been well reported. The underlying mechanism is mainly enhanced lipolysis and ketone bodies’ reabsorption. They also stimulate the pancreatic alpha cells and inhibit the beta...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Endocr Soc
Hauptverfasser: Somagutta, Manoj Reddy, Pormento, Maria Kezia Lourdes L, Hange, Namrata, Khan, Muhammad Adnan, Jain, Molly S, Hanan, Saad, Batti, Erkan, Kaur, Jaspreet, Iloeje, Obumneme Jude, Pagad, Sukrut
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2021
Schlagworte:
Diabetes Mellitus and Glucose Metabolism
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8090176/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.967
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge